TABLE 2:

Treatment Outcome Based on Lesion Location

Location of Treated Prostate Cancer	Residual Clinically Significant Prostate Cancera
Left anteriortransition zone base	Yes
Right posterior peripheral zone apex	Yes
Right anteriortransition zone base	No
Right posterior peripheral zone midgland	Yes
Right posterior peripheral zone apex	No
Left anterior peripheral zone apex	No
Left posterior peripheral zone midgland	Yes
Left anterior peripheral zone midgland	Yes
Right anteriortransition zone base	Yes
Right posterior peripheral zone midgland	Yes
Left anteriortransition zone base	Yes
Left posterior peripheral zone midgland	Yes
Right anteriortransition zone midgland	No
Left anteriortransition zone base	No
Left posterior transition zone base	Yes
Right posterior peripheral zone midgland	No
Left anteriortransition zone midgland	Yes
Left anterior peripheral zone apex	No

Note—Lesion location defined according to Prostate Imaging Reporting and Data System version 2 sector map. For peripheral zone lesions in the apex and midgland, posteromedial and posterolateral locations are referred to as posterior.

^aDefined as Gleason score 3 + 4 or greater. Among the three patients with Gleason 3 + 3 at baseline, clinically significant prostate cancer was defined as any residual prostate cancer.